financetom
NAUT
financetom
/
Healthcare
/
NAUT
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Nautilus Biotechnology, Inc.NAUT
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
91.58M
Revenue (ttm)
n/a
Net Income (ttm)
-70.78M
Shares Out
126.15M
EPS (ttm)
-0.56
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
39,760
Open
0.7340
Previous Close
0.7395
Day's Range
0.7121 - 0.7340
52-Week Range
0.6600 - 3.0900
Beta
1.21
Analysts
Hold
Price Target
3.58 (+393.11%)
Earnings Date
Apr 29, 2025
Description >

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.

It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis.

The company was incorporated in 2016 and is headquartered in Seattle, Washington.

Copyright 2023-2025 - www.financetom.com All Rights Reserved